Regenerative Medical Technology Group Inc. Stock
Equities
MSSV
US59071L1035
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0207 USD | -50.71% |
|
-54.30% | +183.56% |
Sales 2022 | 1.53M 2.1M | Sales 2023 | 2.41M 3.31M | Capitalization | 91.2K 125K |
---|---|---|---|---|---|
Net income 2022 | -5M -6.87M | Net income 2023 | -9M -12.37M | EV / Sales 2022 | 8.97 x |
Net Debt 2022 | 13.5M 18.55M | Net Debt 2023 | 17.12M 23.53M | EV / Sales 2023 | 7.14 x |
P/E ratio 2022 |
-0.04
x | P/E ratio 2023 |
-0.01
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.19% |
1 day | -50.71% | ||
1 week | -54.30% | ||
Current month | -47.59% | ||
1 month | -42.50% | ||
3 months | -58.18% | ||
6 months | +155.56% | ||
Current year | +183.56% |
![Extreme 0.0207](/images/extremecours_fleche.png)
![Extreme 0.0207](/images/extremecours_fleche.png)
![Extreme 0.0073](/images/extremecours_fleche.png)
![Extreme 0.0072](/images/extremecours_fleche.png)
![Extreme 0.0072](/images/extremecours_fleche.png)
![Extreme 0.0072](/images/extremecours_fleche.png)
![Extreme 0.0072](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 19-11-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 19-11-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-17 | 0.0207 | -50.71% | 33,626 |
24-06-14 | 0.042 | +19.69% | 100 |
24-06-13 | 0.0351 | -27.80% | 17,300 |
24-06-12 | 0.0486 | +7.28% | 4,627 |
Delayed Quote OTC Markets, June 17, 2024 at 01:02 pm
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+183.56% | 259K | |
+38.66% | 52.85B | |
-7.81% | 38.87B | |
+35.60% | 38.24B | |
-10.77% | 26.79B | |
+11.77% | 26.16B | |
-17.82% | 19.9B | |
+35.09% | 13.18B | |
+29.17% | 12.24B | |
-3.05% | 11.79B |
- Stock Market
- Equities
- MSSV Stock